Lessons learned from a recent FDA warning letter highlighting systematic issues with risk analysis, CAPA and design controls.
Share this post
Case Study: When Underestimating Risk Leads…
Share this post
Lessons learned from a recent FDA warning letter highlighting systematic issues with risk analysis, CAPA and design controls.